Clinical pharmacokinetics of voriconazole.
This review presents the published clinical pharmacokinetic data for the antifungal agent voriconazole. Aspects regarding absorption, tissue distribution, elimination and kinetic interactions are also discussed.
Levêque
Dominique
D
Department of Pharmacy, Hôpital Hautepierre, Avenue Molière, 67000 Strasbourg, France. dominique.leveque@chru-strasbourg.fr
Nivoix
Yasmine
Y
Jehl
François
F
Herbrecht
Raoul
R
D000042:Absorption; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D008657:Metabolic Clearance Rate; D011743:Pyrimidines / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D014018:Tissue Distribution; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole